— Know what they know.
Not Investment Advice
Also trades as: RCE.AX (ASX) · $vol 0M

RECEF Earnings

Recce Pharmaceuticals Ltd
1W: +0.0% 1M: +0.0% 3M: +0.0% YTD: +0.0% 1Y: -63.3%
$0.22
+0.00 (+0.00%)
 
OTC · Healthcare · Biotechnology · Tech Score Strong Sell · Power 39 · $67.3M mcap · 162M float · 0.0000% daily turnover
Last Earnings 2026-08-31
EPS
A$0.00 (US$0.00)
▲ Beat +0.0%
Revenue
—

Estimate vs Actual

Earnings Surprise History

0/16
EPS Beats
1/16
Revenue Beats
0%
EPS Beat Rate
6%
Rev Beat Rate

Wall Street Forward Estimates

Quarterly
Annual

Estimate Revisions

Recent Revisions
DatePeriodFiscal DateEPS OldEPS NewChangeRev OldRev New
2026-10-02 annual 2027-06-30 A$-0.09 A$-0.09 — A$8,918,272 A$8,867,964
2026-10-02 annual 2028-06-30 A$0.11 A$0.11 — A$48,294,073 A$48,021,647
2026-10-01 annual 2027-06-30 A$-0.09 A$-0.09 — A$8,967,302 A$8,918,272
2026-10-01 annual 2028-06-30 A$0.11 A$0.11 — A$48,559,585 A$48,294,073
2026-09-29 annual 2027-06-30 A$-0.09 A$-0.09 — A$8,951,470 A$8,967,302
2026-09-29 annual 2028-06-30 A$0.11 A$0.11 — A$48,473,847 A$48,559,585
2026-09-28 annual 2027-06-30 A$-0.09 A$-0.09 — A$9,090,901 A$8,951,470
2026-09-28 annual 2028-06-30 A$0.11 A$0.11 — A$49,228,895 A$48,473,847
2026-09-22 annual 2027-06-30 A$-0.09 A$-0.09 — A$9,087,326 A$9,090,901
2026-09-22 annual 2028-06-30 A$0.11 A$0.11 — A$49,209,535 A$49,228,895
2026-09-21 annual 2027-06-30 A$-0.09 A$-0.09 — A$9,075,707 A$9,087,326
2026-09-21 annual 2028-06-30 A$0.11 A$0.11 — A$49,146,614 A$49,209,535
2026-09-21 annual 2027-06-30 A$-0.09 A$-0.09 — A$9,152,445 A$9,075,707
2026-09-21 annual 2028-06-30 A$0.11 A$0.11 — A$49,562,168 A$49,146,614
2026-09-15 annual 2027-06-30 A$-0.09 A$-0.09 — A$9,131,505 A$9,152,445
Earnings Call Transcripts
No transcripts available.

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms